LISTADO DE MEDICAMENTOS TRAZADORES COMO HERRAMIENTA EN PROGRAMAS DE FARMACOSEGURIDAD

2017 ◽  
Vol 42 (1) ◽  
Author(s):  
Olga Lucia Molina Rua
Keyword(s):  
Safe Medication ◽  
Seguimiento Farmacoterapéutico

Los resultados negativos a la medicación o problemas de seguridad, incluyendo las reacciones adversas a medicamentos (RAM) son un problema clínico relevante, debido a su alta incidencia y a los efectos nocivos en la salud. El objetivo de este trabajo fue estructurar un listado de medicamentos a partir de la revisión de estudios clínicos que evidencian la utilización de medicamentos que cumplen con los parámetros de medicamento trazador, los cuales tienen mayor probabilidad de causar resultados negativos a la medicación, problemas de seguridad o identificar RAM producidas por otros medicamentos, como herramienta útil para identificar los pacientes que más se pueden beneficiar de los programas de seguimiento farmacoterapéutico o farmacoseguridad. Inicialmente, se realizó una revisión estructurada en PubMed/Medline de estudios relacionados con el reporte de medicamentos asociados a la presentación de RAM, clasificadas como graves o moderadas y con una frecuencia igual o superior al 10%. Posteriormente, el listado de medicamentos identificado, fue complementado con medicamentos de alta alerta del Institute for Safe Medication Practices (ISMP) y con medicamentos utilizados para el tratamiento de RAM o antídotos, con un resultado de 139 medicamentos incluidos en el Listado general de medicamentos trazadores, aplicado al ámbito mundial. Los medicamentos trazadores identificados son una herramienta para identificar y seleccionar los pacientes que más se podrían beneficiar de los programas de seguimiento farmacoterapéutico o farmacoseguridad en las instituciones de salud, sin embargo, se propone la realización de estudios diseñados para evaluar la utilidad práctica de dicho listado según las condiciones de cada población.

Safety Issues with Patient-Controlled Analgesia; Wake-Up Call: Unlabeled Containers Lead to Patient's Death

2005 ◽  
Vol 40 (2) ◽  
pp. 117-126
Author(s):  
Michael R. Cohen
Keyword(s):  
Medication Errors ◽  
Web Sites ◽  
Health Care Facilities ◽  
Inservice Training ◽  
Patient Controlled Analgesia ◽  
Safe Medication ◽  
Safety Issues ◽  
Care Facilities ◽  
Fail Safe ◽  
E Mail

These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them in your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the USP Medication Errors Reporting Program (MERP), which is presented in cooperation with the Institute for Safe Medication Practices. If you have encountered medication errors and would like to report them, you may call USP toll-free, 24 hours a day, at 800-233-7767 (800-23-ERROR). Any reports published by ISMP will be anonymous. Comments are also invited; the writers’ names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported through the ISMP ( www.ismp.org ) or USP ( www.usp.org ) Web sites or communicated directly to ISMP by calling 1-800-FAIL SAFE or via e-mail at [email protected] . ISMP guarantees the confidentiality and security of the information received and respects reporters’ wishes as to the level of detail included in publications.

Clinicians Often Unaware of Colchicine Dose Limits; What is a “Bolus?”; Drug Information Leaflets can Help Prevent Errors

2002 ◽  
Vol 37 (4) ◽  
pp. 355-356
Author(s):  
Michael R. Cohen
Keyword(s):  
Health Care ◽  
Medication Errors ◽  
Training Programs ◽  
Drug Information ◽  
Health Care Facilities ◽  
Inservice Training ◽  
Safe Medication ◽  
Information Leaflets ◽  
Care Facilities ◽  
Dose Limits

These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them in your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the USP Medication Errors Reporting Program, which is presented in cooperation with the Institute for Safe Medication Practices. If you have encountered medication errors and would like to report them, you may call USP toll-free, 24 hours a day, at 800-233-7767 (800-23-ERROR). Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below.

Ongoing Incidents Involving Fentanyl Patches are Alarming!; Insulin CONCENTRATE U-500; WHO: Dilute Vincristine in a Minibag

2007 ◽  
Vol 42 (10) ◽  
pp. 884-887 ◽  
Author(s):  
Michael R. Cohen ◽  
Judy L. Smetzer
Keyword(s):  
Medication Errors ◽  
Web Sites ◽  
Training Programs ◽  
Health Care Facilities ◽  
Level Of Detail ◽  
Inservice Training ◽  
Safe Medication ◽  
Care Facilities ◽  
Fail Safe ◽  
E Mail

These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work. Through education and alertness of personnel and procedural safeguards, they can be avoided. You should consider publishing accounts of errors in your newsletters and/or presenting them in your inservice training programs. Your assistance is required to continue this feature. The reports described here were received through the USP Medication Errors Reporting Program (MERP), which is presented in cooperation with the Institute for Safe Medication Practices. If you have encountered medication errors and would like to report them, you may call USP toll-free, 24 hours a day, at 800-233-7767 (800-23-ERROR). Any reports published by ISMP will be anonymous. Comments are also invited; the writers' names will be published if desired. ISMP may be contacted at the address shown below. Errors, close calls, or hazardous conditions may be reported through the ISMP ( www.ismp.org ) or USP ( www.usp.org ) Web sites or communicated directly to ISMP by calling 800-FAIL-SAFE or via e-mail at [email protected] . ISMP guarantees the confidentiality and security of the information received and respects reporters' wishes as to the level of detail included in publications.

Safe Medication Compounding

2013 ◽  
Vol 28 (2) ◽  
pp. 110-112
Author(s):  
Julie A. Golembiewski ◽  
Sheena Farragut Babin
Keyword(s):  
Safe Medication

Safe medication practices

2003 ◽  
Vol 24 (5) ◽  
pp. 314-317 ◽  
Author(s):  
Carol A Miller
Keyword(s):  
Safe Medication

scholarly journals Desarrollo de una guía de seguimiento farmacoterapéutico de pacientes pediátricos con enfermedad renal crónica

2021 ◽  
Vol 62 (3) ◽  
pp. 249-259
Author(s):  
Kattia Bermúdez Carvajal ◽  
María Soledad Quesada ◽  
Adriana Brenes Aguilar ◽  
Gloria Arias Porras
Keyword(s):  
Costa Rica ◽  
Seguimiento Farmacoterapéutico

Introducción: A nivel latinoamericano, existen estudios sobre el desarrollo e implementación de programas de atención farmacéutica en pacientes pediátricos con resultados positivos en los pacientes y sus cuidadores. Sin embargo, en el caso de Costa Rica, solamente hay reportados estudios en hospitales que atienden población adulta. Objetivo: Desarrollar una guía de seguimiento farmacoterapéutico (SFT) para pacientes pediátricos con enfermedad renal crónica (ERC), atendidos en el Hospital Nacional de Niños Dr. Carlos Sáenz Herrera (HNN), para mejorar la adherencia a la terapia y el uso adecuado de la medicación. Métodos: Se realizó una búsqueda bibliográfica sobre la enfermedad y sobre diferentes programas de atención farmacéutica para elaborar la guía de atención farmacéutica y SFT. Por último, se elaboraron y validaron materiales educativos dirigidos a los cuidadores y niños atendidos en el servicio de nefrología. Resultados: Se desarrolló y validó una guía de SFT. Esta incluyó las siguientes secciones: recopilación de datos demográficos, desarrollo de la consulta, fase de estudio y registro. Se adaptó un instrumento de medición de adherencia para ser usado en la población pediátrica. Se desarrollaron y validaron cuatro materiales educativos. Conclusiones: El protocolo y recursos informativos planteados fueron considerados, por los farmacéuticos del Hospital Nacional de Niños, herramientas de utilidad y aplicabilidad para brindar una atención integral a pacientes del servicio de Nefrología y promover la adherencia terapéutica de los pacientes.

Sign in / Sign up

Export Citation Format

Share Document